Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 12,896,000 | 12,779,000 | 13,627,000 | 13,045,000 | 13,147,000 |
| Cost of Goods | 2,660,000 | 2,468,000 | 3,212,000 | 3,085,000 | 3,174,000 |
| Gross Profit | 10,236,000 | 10,311,000 | 10,415,000 | 9,960,000 | 9,973,000 |
| Operating Expenses | 6,495,000 | 6,301,000 | 8,659,000 | 6,939,000 | 6,496,000 |
| Operating Income | 3,741,000 | 4,010,000 | 1,756,000 | 3,021,000 | 3,477,000 |
| Other Income | 74,000 | -59,000 | -980,000 | -1,417,000 | -1,067,000 |
| Pre-tax Income | 3,815,000 | 3,951,000 | 776,000 | 1,604,000 | 2,410,000 |
| Income Tax | 739,000 | 821,000 | 14,000 | 249,000 | 347,000 |
| Net Income Continuous | 3,077,000 | 3,130,000 | 764,000 | 1,355,000 | 2,062,000 |
| Net Income Discontinuous | 2,000 | N/A | 15,000 | N/A | 1,000 |
| Minority Interests | 5,000 | 9,000 | 6,000 | N/A | 16,000 |
| Net Income | $3,073,000 | $3,121,000 | $774,000 | $1,355,000 | $2,047,000 |
| EPS Basic Total Ops | 0.52 | 0.52 | 0.13 | 0.22 | 0.34 |
| EPS Basic Continuous Ops | 0.52 | 0.52 | 0.13 | 0.22 | 0.34 |
| EPS Diluted Total Ops | 0.51 | 0.51 | 0.13 | 0.22 | 0.33 |
| EPS Diluted Continuous Ops | 0.51 | 0.51 | 0.13 | 0.22 | 0.33 |
| EBITDA(a) | $5,315,000 | $5,565,000 | $3,305,000 | $4,417,000 | $4,864,000 |